AngioDynamics Inc at Canaccord Genuity Growth Conference Transcript
()-
Morning everyone, get to kick this off. So, thank you so much for joining us for the Canaccord's 43 Annual Global Growth Conference. I'm Jon Young, member of the MedTech research team here. And I have the pleasure of hosting AngioDynamics, our first chat today with us, Jim Clemmer, CEO, and Steve Trowbridge, CFO. On the format today is a brief overview presentation, and then we followed by a fireside Q&A session. And with that, I'd like to invite Jim to the podium. Thank you.
Great, and good morning. Thanks Jon, and thanks to Canaccord for inviting us to your conference. So let me tell you about AngioDynamics, but before I do, I'll remind you check your forward-looking statements, you know that everything I tell you today, will be our best projections of strategies and what we'll do, but I can't guarantee that everything will happen. So please understand the risks of investing.
So let me talk
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
